This company seems to have been delisted
Reason: Merged with Viewpoint Molecular
Last recorded trade on: April 21, 2023
Source: https://isoray.com/2023/02/isoray-completes-merger-with-viewpoint-molecular-targeting-to-advance-new-treatment-paradigm-in-targeted-precision-oncology-medicine/
Reason: Merged with Viewpoint Molecular
Last recorded trade on: April 21, 2023
Source: https://isoray.com/2023/02/isoray-completes-merger-with-viewpoint-molecular-targeting-to-advance-new-treatment-paradigm-in-targeted-precision-oncology-medicine/
Isoray
ISR
$0.69
Share price
0.00%
Change (1 day)
47.70%
Change (1 year)
Categories
Market capitalization of Isoray (ISR)
Last known market cap: NZ$0.19 Billion
On April 21, 2023 Isoray had a market cap of NZ$0.19 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Isoray from 2003 to 2023
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2023 | NZ$0.16 B | 205.92% |
| 2022 | NZ$55.3 M | -31.35% |
| 2021 | NZ$80.57 M | 48.11% |
| 2020 | NZ$54.39 M | -12.93% |
| 2019 | NZ$62.47 M | 107.47% |
| 2018 | NZ$30.11 M | -2.65% |
| 2017 | NZ$30.93 M | -32.85% |
| 2016 | NZ$46.06 M | -38.87% |
| 2015 | NZ$75.35 M | -26.32% |
| 2014 | NZ$0.10 B | 337.49% |
| 2013 | NZ$23.37 M | -28.74% |
| 2012 | NZ$32.8 M | 32.32% |
| 2011 | NZ$24.79 M | -34.47% |
| 2010 | NZ$37.83 M | 34.59% |
| 2009 | NZ$28.1 M | 255.51% |
| 2008 | NZ$7.9 M | -86.95% |
| 2007 | NZ$60.58 M | -46.54% |
| 2006 | NZ$0.11 B | -20.16% |
| 2005 | NZ$0.14 B | -81.73% |
| 2004 | NZ$0.77 B | -48.88% |
| 2003 | NZ$1.51 B |
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 | NZ$0.28 B | 50.88% | 🇺🇸 USA |
 | NZ$0.66 B | 245.71% | 🇺🇸 USA |
 | NZ$24.54 B | 12,738.23% | 🇺🇸 USA |
 | NZ$317.88 B | 166,169.57% | 🇺🇸 USA |